Tanaka Makoto, Nishikawa Toshiaki
Department of Anesthesia, Akita University School of Medicine, Hondo 1-1-1, Akita-city, Akita-010-8543, Japan.
Anesth Analg. 2002 Nov;95(5):1408-11, table of contents. doi: 10.1097/00000539-200211000-00056.
Accidental intravascular injection of an epinephrine-containing test dose decreases the T-wave amplitude of a Lead II electrocardiogram (EKG) with 100% sensitivity and specificity on the basis of the T-wave criterion (positive if there is a > or =25% decrease in amplitude). We designed this study to test whether the choice of EKG lead would affect the efficacy of the simulated intravascular test dose in anesthetized patients. After an 8-h fast and no premedication, 35 healthy patients were anesthetized with end-tidal 2% sevoflurane and nitrous oxide after endotracheal intubation. When hemodynamic stability was obtained, all subjects received 3 mL of normal saline IV, followed 4 min later by 1.5% lidocaine 3 mL plus 15 microg of epinephrine (1:200,000) IV. Heart rate, systolic blood pressure, Leads II (n = 35) and V(5) (n = 35), and either Lead I (n = 17) or III (n = 18), whichever had the greater T-wave amplitude, were continuously recorded for 4 min after the saline and test-dose injections. An IV test dose produced significant increases in heart rate and systolic blood pressure and produced decreases in the T-wave amplitude of all EKG leads studied in all subjects, whereas IV saline elicited no changes in these variables. The maximum percentage decreases in T-wave amplitude of Leads II, I, III, and V(5) were -87% +/- 13%, -88% +/- 8%, -94% +/- 15%, and -86% +/- 16%, respectively (mean +/- SD; P > 0.05). There was no significant difference in temporal changes in T-wave amplitude among the 4 leads, and sensitivity and specificity were 100% on the basis of the T-wave criterion, irrespective of the lead examined. Our results indicate that Leads II, I, III, and V(5) of the EKG are equally effective for detecting intravascular injection of the epinephrine-containing test dose in sevoflurane-anesthetized adults.
To determine whether an epidural catheter is in a blood vessel, an epidural test dose containing 15 microg of epinephrine is used. We found that decreases in the T-wave amplitude of Leads I, II, III, and V(5) of the electrocardiogram were equally sensitive and specific for detecting intravascular injection of the test dose in sevoflurane-anesthetized adult patients.
意外血管内注射含肾上腺素的试验剂量会使II导联心电图(EKG)的T波振幅降低,根据T波标准,其敏感性和特异性均为100%(如果振幅降低≥25%则为阳性)。我们设计本研究以测试心电图导联的选择是否会影响模拟血管内试验剂量在麻醉患者中的效果。35例健康患者禁食8小时且未使用术前用药,经气管插管后用2%七氟醚和氧化亚氮进行麻醉。血流动力学稳定后,所有受试者静脉注射3 mL生理盐水,4分钟后静脉注射3 mL 1.5%利多卡因加15 μg肾上腺素(1:200,000)。在注射生理盐水和试验剂量后持续记录4分钟的心率、收缩压、II导联(n = 35)和V5导联(n = 35),以及I导联(n = 17)或III导联(n = 18)中T波振幅较大的那个导联。静脉注射试验剂量使所有受试者研究的所有心电图导联的心率和收缩压显著升高,T波振幅降低,而静脉注射生理盐水对这些变量无影响。II、I、III和V5导联T波振幅的最大百分比降低分别为-87%±13%、-88%±8%、-94%±15%和-86%±16%(均值±标准差;P>0.05)。4个导联的T波振幅随时间的变化无显著差异,根据T波标准,无论检查哪个导联,敏感性和特异性均为100%。我们的结果表明,在七氟醚麻醉的成年人中,心电图的II、I、III和V5导联在检测含肾上腺素试验剂量的血管内注射方面同样有效。
为确定硬膜外导管是否在血管内,会使用含15 μg肾上腺素的硬膜外试验剂量。我们发现,心电图I、II、III和V5导联的T波振幅降低在检测七氟醚麻醉成年患者血管内注射试验剂量方面同样敏感且特异。